Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Praram 9 Hospital PCLBKK:PR9 -0.56%86 EV-to-EBIT is 11.37 as of Aug. 15, 2026, which is 41% below its 10-year median of 19.27. GuruFocus rates BKK:PR9 with a GF Score™ of 86/100 and a GF Value™ of ฿23.71 (Modestly Undervalued). Among 472 Healthcare Providers & Services companies, Praram 9 Hospital PCL ranks better than 68.01% on this metric.
The historical rank and industry rank for Praram 9 Hospital PCL's EV-to-EBIT or its related term are showing as below:
BKK:PR9'
s EV-to-EBIT Range Over the Past 10 Years
Min: 9.86 Med: 19.27 Max: 37.6
Current: 11.36
During the past 12 years, the highest EV-to-EBIT of Praram 9 Hospital PCL was 37.60. The lowest was 9.86. And the median was 19.27.
BKK:PR9's EV-to-EBIT is ranked better than 68.01% of 472
companies
in the Healthcare Providers & Services industry
Industry Median: 15.715
vs BKK:PR9: 11.36
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Praram 9 Hospital PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿10,182 Mil.
Praram 9 Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿993 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Praram 9 Hospital PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Praram 9 Hospital PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Praram 9 Hospital PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Praram 9 Hospital PCL's EV-to-EBIT falls into.
Praram 9 Hospital PCL's current Enterprise Value is ฿11,283 Mil.
Praram 9 Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿993 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Praram 9 Hospital PCL (BKK:PR9) has a EV-to-EBIT of 11.37 as of Aug. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Praram 9 Hospital PCL and its competitors. This is 41% below median its historical median of 19.27. Over the past decade, Praram 9 Hospital PCL's EV-to-EBIT has ranged from 9.86 to 37.60. According to the industry distribution chart, Praram 9 Hospital PCL ranks #151 out of 472 companies in the Healthcare Providers & Services industry, placing it in the top 32%.
Is Praram 9 Hospital PCL's EV-to-EBIT too high?
Praram 9 Hospital PCL's current EV-to-EBIT of 11.37 is 41% below median its 10-year median of 19.27. Over the past 10 years, this metric has ranged from a low of 9.86 to a high of 37.60. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. Praram 9 Hospital PCL's value of 11.37 is 27.6% below this industry median. Based on the distribution chart, Praram 9 Hospital PCL ranks #151 out of 472 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Praram 9 Hospital PCL has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Praram 9 Hospital PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Praram 9 Hospital PCL ranks #151 out of 472 companies for EV-to-EBIT. This puts Praram 9 Hospital PCL in the upper half of its industry. The industry median EV-to-EBIT is 15.72. Praram 9 Hospital PCL's value of 11.37 is 27.6% below this benchmark. Historically, Praram 9 Hospital PCL's own EV-to-EBIT has ranged from 9.86 to 37.60 over the past decade. While the company's 10-year median is 19.27 vs. the industry median of 15.72, Praram 9 Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Praram 9 Hospital PCL's current EV-to-EBIT of 11.37 is 27.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Praram 9 Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Praram 9 Hospital PCL's current EV-to-EBIT is 11.37, which is 41% below median its own 10-year median of 19.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Praram 9 Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Praram 9 Hospital PCL (BKK:PR9) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿23.71, compared to a current price of ฿17.90 — trading 24.5% below its estimated fair value. The current EV-to-EBIT is 11.37, which is 41% below median its 10-year median of 19.27 and 27.6% below the Healthcare Providers & Services industry median of 15.72. Praram 9 Hospital PCL's overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Praram 9 Hospital PCL (BKK:PR9), the current EV-to-EBIT is 11.37 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Praram 9 Hospital PCL (BKK:PR9) Overvalued in 2026?
Based on GuruFocus' analysis, Praram 9 Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.90 is trading 24.5% below its estimated GF Value™ of ฿23.71.
GuruFocus considers Praram 9 Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:PR9:
EV-to-EBIT: 11.37 (41% below median its 10-year median of 19.27)
GF Value™: ฿23.71 vs. price of ฿17.90 (24.5% below fair value)
Industry Position: 27.6% below the Healthcare Providers & Services median (#151 of 472)
No single metric tells the full story. See the BKK:PR9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Praram 9 Hospital PCL is engaged in hospital operations in Bangkok. The company operates an overnight general hospital under the name of Praram 9 Hospital. The revenue derived from hospital operations mainly consists of medical fees, hospital room sales, and medicine sales. Geographically, the company operates only in Thailand.
86GF Score
Get the complete analysis for BKK:PR9
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PR9 has been successfully added to your 
